Scarica l'app Stockscreener
3.32
1.22%
0.04
Dopo l'orario di chiusura:
3.27
-0.05
-1.51%
Chemomab Therapeutics Ltd Adr Borsa (CMMB) Ultime notizie
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up - Zacks Investment Research
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - sharewise.com
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals - Zacks Investment Research
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain - sharewise.com
TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder - Yahoo Finance
Chemomab Therapeutics (NASDAQ:CMMB) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza - sharewise.com
OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data - sharewise.com
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure - The Globe and Mail
AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study - Yahoo Finance
Oppenheimer raises Chemomab stock price target to $25 on M&A potential By Investing.com - Investing.com South Africa
Oppenheimer raises Chemomab stock price target to $25 on M&A potential - Investing.com Nigeria
Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer - TipRanks
CMMB’s Market Whiplash: -34.81% YTD Decline, -15.11% Plunge in 30 Days - investchronicle.com
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy - sharewise
KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail
MRK's ADC Drug Combo Shows Antitumor Activity in Lymphoma Study - sharewise
NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study - Yahoo Finance
CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer - sharewise
RCKT Stock Tanks On Patient Death In Danon Disease Study - Barchart.com
RCKT Stock Tanks on Patient Death in Danon Disease Study - Yahoo Finance
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance
Chemomab prepares for annual shareholder meeting By Investing.com - Investing.com India
Chemomab prepares for annual shareholder meeting - Investing.com
Chemomab Leadership Changes Signal Strategic Momentum Following Positive Clinical Results - Barchart.com
HUTCHMED and AstraZeneca Announce that TAGRISSO® Plus Savolitinib Demonstrated 49% Objective Response Rate in Lung Cancer Patients with High Levels of MET Overexpression and/or Amplification in SAVANNAH Phase II Trial - Barchart.com
Microsoft Stock After Xbox Price Hike: Buy Or Hold? - Barchart.com
Should You Buy, Sell, Or Hold Nio Stock Amid Firefly Brand Launch? - Barchart.com
UBS Group Q1 Earnings & Revenues Dip Y/Y, Credit Loss Expenses Slip - Barchart.com
This ‘Strong Buy’ Robotaxi Stock Just Got A Huge Bump. Should You Buy Shares Now? - Barchart.com
Chemomab reports promising PSC treatment data - Investing.com
Chemomab Announces New Medical And Clinical Appointments - Barchart.com
Should You Buy Tesla Stock On The ‘Liberation Day’ Dip? - Barchart.com
Should You Dump Tesla Stock As Deliveries Plunge In Q1 And Tariff Fears Escalate? - Barchart.com
Nebokitug shows promise in PSC treatment trial - Investing.com
Q3 Rundown: Sea (NYSE:SE) Vs Other Online Marketplace Stocks - Barchart.com
Is WeRide Stock A Buy, Sell, Or Hold As Nvidia Reveals Its $25 Million Bet? - Barchart.com
Arm Just Nabbed A Major Chip Deal With Meta. Is ARM Stock A Buy, Sell, Or Hold Now? - Barchart.com
港股美國預託證券與本港收市比較個別發展 - Yahoo 財經
Nvidia Sends Chinese Self-Driving Stock Up 100%, While Soundhound AI Sells Off - Barchart.com
Up 175% In 2024, Can This Growth Stock Keep Climbing? - Barchart.com
3 Stocks To Benefit From China’s Rare Earth Export Ban On U.S. - Barchart.com
Is Toyota Stock A Buy, Sell, Or Hold On New Return On Equity Plans? - Barchart.com
3 Pharma Stocks To Buy As California Sounds The Alarm On Bird Flu Cases - Barchart.com
What's Going On With Alibaba Stock? - Barchart.com
Up 47% Post-Election, Can Tesla Stock Keep Soaring? - Barchart.com
Under Trump, European Defense Stocks Will Soar. Here's How To Invest. - Barchart.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):